Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects with Mild to Moderate Persistent Asthma

Trial Identifier: PT008001
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02105012
Start Date: April 2014
Primary Completion Date: September 2015
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, CA Los Angeles, CA, United States
United States, CA Rolling Hills Estates, CA, United States
United States, CA Stockton, CA, United States
United States, MA North Dartmouth, MA, United States
United States, NC Charlotte, NC, United States
United States, NJ Skillman, NJ, United States
United States, OH Columbus, OH, United States
United States, OH Sylvania, OH, United States
United States, OK Oklahoma City, OK, United States
United States, OR Lake Oswego, OR, United States
United States, OR Medford, OR, United States
United States, SC Spartanburg, SC, United States
United States, TX El Paso, TX, United States
United States, TX San Antonio, TX, United States
US, AL Athens, AL, US
US, AL Birmingham, AL, US
US, AL Foley, AL, US
US, CA San Diego, CA, US
US, FL Clearwater, FL, US
US, FL Clermont, FL, US
US, FL Miami, FL, US
US, FL Orlando, FL, US
US, FL Ormond Beach, FL, US
US, FL Sebring, FL, US
US, FL St Cloud, FL, US
US, FL Tampa, FL, US
US, IL Blue Island, IL, US
US, MISSOURI Hazelwood, MISSOURI, US
US, NC Winstom-Salem, NC, US
US, OH Cincinnati, OH, US
US, OH Dayton, OH, US
US, OH Middleburg Heights, OH, US
US, OH Oregon, OH, US
US, OH Toledo, OH, US
US, SC Greenville, SC, US
US, SD Rapid CIty, SD, US
US, TN Tullahoma, TN, US
US, TX Houston, TX, US
US, TX Plano, TX, US
US, WA Everett, WA, US